GN–G4 was highly expressed in 17 human malignancies, including adenoid cystic carcinoma (ACC), invasive breast cancer (BRCA), bile duct cell carcinoma (CHOL), and colonic adenocarcinoma (COAD) (Figure 1I). Here, GNG4 is linked to adenoid cystic carcinoma.